FDA cleared the Arctic Sun Neonatal ArcticGel Pad from Medivance, Inc. on Oct 30, 2026 under K263587, a special 510(k). The device falls under product code DWJ, System, Thermal Regulating, regulated at 21 CFR 870.5900 as a Class 2 device. The review panel was Cardiovascular.
FDA logged the submission as received on Sep 30, 2026. The decision came 30 days later, inside the 90 FDA-day goal for a 510(k).
This is the only decision on file for Medivance, Inc. in the last 12 months of the tracker.
Questions & Answers
What did FDA clear under K263587?
K263587 is the FDA 510(k) for Arctic Sun Neonatal ArcticGel Pad, submitted by Medivance, Inc.. FDA's decision date was Oct 30, 2026, under product code DWJ (System, Thermal Regulating).
Who makes the Arctic Sun Neonatal ArcticGel Pad?
Medivance, Inc., based in Louisville, CO, is the applicant of record for K263587.
How long did the K263587 review take?
FDA received the submission on Sep 30, 2026 and issued its decision on Oct 30, 2026, 30 days later.